Nanobots Therapeutics successfully closes a Pre-Seed funding round of €478,000 [22-09-2023]
The start-up specializes in the development of biocompatible nanorobots capable of delivering drugs to difficult-to-treat tumors more efficiently and safely than current therapies. Nanobots Therapeutics is the third investment in the fifth edition of Banco Sabadell’s BStartup Health program, which received applications from 127 start-ups.
Related News
A nanotechnology‐based CRISPR/Cas9 delivery system for genome editing in cancer treatment [01-02-2024]
Metal-free graphene quantum dots show promise for highly efficient tumor therapy [12-01-2024]
Nanomedicine, Graphene, Quantum Science
Using AI, researchers identify a new class of antibiotic candidates that can kill a drug-resistant bacterium [20-12-2023]
Nanobiotechnology, Nanomedicine, Artificial intelligence
Researchers propose new strategy to improve efficiency for nanotherapeutic delivery in tumors [23-10-2023]
Postdoctoral fellowship for Women in Science [21-09-2023]
Nanobiotechnology, Nanotechnologies

© Phantoms Foundation 2024